Tag Archives: NVLS

Top 10 Tech Stocks To Buy For 2018

Related NUAN Watch These 8 Huge Put Purchases In Wednesday Trade Benzinga's Option Alert Recap From May 9
Related NBR Mid-Afternoon Market Update: LeMaitre Vascular Rises After Strong Q1 Results; Synchronoss Technologies Shares Plunge 20 Biggest Mid-Day Losers For Thursday

On CNBC's Fast Money Halftime Report, Jon Najarian spoke about high options activity in Nuance Communications Inc. (NASDAQ: NUAN). Traders were buying the June 19 calls for $1. The trade breaks even at $20 or 2.20 percent above the closing price on Wednesday. Najarian followed the trade and he is going to hold the position for two weeks.

Pete Najarian was watching Nabors Industries Ltd. (NYSE: NBR). He said that the stock has been trading in a range between $8 and $18 over the last 52 weeks and although it spiked 2.82 percent on Wednesday, it's still close to the lower end of the range. Anticipating a move higher, traders were buying the June 11 calls for $0.30. Around 6,000 contracts were bought in the first half of the session. The trade breaks even at $11.30 or 10.78 percent above the current market price. Pete Najarian decided to buy the calls and he is going to hold them for 4-5 weeks.

Top 10 Tech Stocks To Buy For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) is estimated to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion.

    CIGNA Corporation (NYSE: CI) is projected to report its quarterly earnings at $2.15 per share on revenue of $10.00 billion.

  • [By Paul Ausick]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) dropped more than 17% on Friday to post a new 52-week low of $45.44 after closing at $55.00 on Thursday. The stock’s 52-week high is $69.80. Volume was more than 10 times the daily average of around 4.2 million shares. The company’s president has been replaced as an investigation into possible corruption charges begins.

  • [By Lee Jackson]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) is starting to show up as a stock to buy for many of the Wall Street firms we cover. The company was very bullish at the conference and cited a very solid demand environment that is expected to continue through next year. The Deutsche Bank target for the stock is placed at $92, while the consensus number is at $87.

Top 10 Tech Stocks To Buy For 2018: Finisar Corporation(FNSR)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of optical component companies have dropped today, includingOclaro (NASDAQ:OCLR), Acacia (NASDAQ:ACIA), Lumentum (NASDAQ:LITE), and Finisar (NASDAQ:FNSR), whose shares were down 11%, 11%, 6%, and 3%, respectively, as of 3:30 p.m. EDT, after the U.S. broadened its investigation regarding compliance with sanctions programs.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Lisa Levin]

    Shares of Foresight Autonomous Holdings ADR (NASDAQ: FNSR) were down 8 percent to $4.34. On Friday, Foresight posted Q3 non-GAAP net loss of $2,086,000, versus a year-ago non-GAAP net loss of $879,000.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Finisar Corporation (NASDAQ: FNSR) reported in-line earnings for its fourth quarter, but issued a weak forecast for the current quarter. Finisar shares jumped 7.76 percent to $27.63 in the after-hours trading session.
    Shares of Booz Allen Hamilton Holding Corporation (NYSE: BAH) dropped over 13 percent in after-hours trading as the company reported a DoJ civil and criminal investigation regarding cost accounting and cost charging practices. Booz Allen shares dipped 13.30 percent to $34.10 in the after-hours trading session.
    Bob Evans Farms Inc (NASDAQ: BOBE) shares declined over 4 percent Thursday after the company reported results for its fourth quarter. The company posted better-than-expected Q4 earnings, while sales missed estimates. Bob Evans shares dropped 4.26 percent to close at $68.99 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Leo Sun]

    Shares of fiber optic components maker Finisar (NASDAQ:FNSR) fell 17% in April due to a big third-quarter miss in mid-March. Its revenue rose 23% annually to $380.6 million, but that missed expectations by $9 million. Earnings rose136% to $0.59 per share, but that also missed estimates by three cents. Finisar’s top and bottom line guidance for the fourth quarter (16% sales growth and 83% earnings growth at the midpoints) also came in below Wall Street estimates.

  • [By Paul Ausick]

    Finisar Corp. (NASDAQ: FNSR) posted a new 52-week low of $17.81 Monday, down about 7.5% after closing at $19.26 on Friday. The 52-week high is $36.85. Volume was about 6.4 million, nearly double the daily average of around 3.4 million shares. The optical technology company had no specific news.

Top 10 Tech Stocks To Buy For 2018: Autohome Inc.(ATHM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Autohome Inc (ADR) (NYSE: ATHM) is estimated to report its quarterly earnings at $1.68 per share on revenue of $1.05 billion.

    Vera Bradley, Inc. (NASDAQ: VRA) is expected to report its quarterly earnings at $0.05 per share on revenue of $106.75 million.

  • [By R. Chandrasekaran]

    The following stocks are rated with Neutral:

    JD.Com Inc(ADR) (NASDAQ: JD). Vipshop Holdings Ltd – ADR (NYSE: VIPS). Autohome Inc (ADR) (NYSE: ATHM). SouFun Holdings Ltd (NYSE: SFUN). Leju Holdings Ltd (ADR) (NYSE: LEJU).
    Underweight Names

    The following stocks are rated Underweight:

Top 10 Tech Stocks To Buy For 2018: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) dropped about 1.9% on Wednesday to post a new 52-week low of $7.30 after closing at $7.44 on Tuesday. The stock’s 52-week high is $30.96. Volume was about 10% below the daily average of around 10 million shares. Analysts at Pacific Crest said that the company’s inventory continues increasing and lowered the firm’s expectations for unit sales in the first fiscal quarter of 2017.

  • [By Peter Graham]

    Small cap Fitbit Inc (NYSE: FIT), which designs products that track everyday health and fitness,is probably the most well know pure play wearables focused stock to investorsin part because is started off as a high flying pioneer in the space and shares had taken off after its 2015 IPO. However, thatshare performance has not lived up to the lofty investor expectations expected of a stock that became synonymous with wearables:

  • [By Todd Campbell]

    Leveraging data to transform healthcare is only in its infancy, but we’re already seeing examples of how wearable technology may help patients. For example, Fitbit(NYSE:FIT)and Apple(NASDAQ:AAPL)sell consumer-electronics devices that measure and report health information, such as activity levels and heart rate, so that people cantrack the progress they’re making toward their health goals, such as weight loss. Soon, data that these wearable devices collect could become even more useful as more sophisticated sensors are incorporated into them.

  • [By Ashley Moore]

    We saw it with GoPro Inc. (Nasdaq: GPRO) and Fitbit Inc. (NYSE: FIT). Both are trading about 90% below their post-IPO peak prices.

    “The thought that any sane investor would buy Snapchat is frightening,” said Money Morning Capital Wave Strategist Shah Gilani. “Buying shares in SNAP is like trying to pick up nickels in front of buses.”

Top 10 Tech Stocks To Buy For 2018: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

Top 10 Tech Stocks To Buy For 2018: Axcelis Technologies Inc.(ACLS)

Advisors’ Opinion:

  • [By Chris Dier-Scalise]

    "We have three stocks that we have identified, Excelis Technologies Inc (NASDAQ: ACLS), Cohu, Inc. (NASDAQ: COHU), and Entegris Inc (NASDAQ: ENTG). All of these companies spiked up on their recent positive earnings surprises and they’ve now pulled back to the point that we think they‘re attractive"

  • [By Anders Bylund]

    Shares of Axcelis Technologies (NASDAQ:ACLS) gained 21.7% in March 2017, according to data from S&P Global Market Intelligence.

    So what

    The maker of manufacturing equipment for semiconductor factories is largely following the medium-term trajectory of the industry-tracking PHLX Semiconductor index. Being a small-cap player in that large sector, Axcelis saw its share prices falling in early March only to whipsaw back to a strong gain on heavy trading volume.

Top 10 Tech Stocks To Buy For 2018: Molex Incorporated(MOLX)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Shares of electronic connector maker Molex Incorporated (MOLX) skyrocketed on Monday morning after reports that the company will be acquired by Koch Industries.

    Koch Industries has agreed to acquire Molex for a total of $7.2 billion. This deal will include all outstanding shares of the company’s Common Stock, Class A Common Stock and Class B Common Stock for $38.50 per share.

    The deal has been approved by the board of directors of both companies. Molex will continue to maintain its current management team and its current headquarters in Lisle, IL.

    Molex shares were up $9.15, or 31.17%, during Monday morning trading. The stock is up 41% YTD.

Top 10 Tech Stocks To Buy For 2018: Rackspace Hosting Inc(RAX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.

Top 10 Tech Stocks To Buy For 2018: Netlist, Inc.(NLST)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Elite Opportunity Pronewsletter suggested small cap data/memory solutions stocksNetlist, Inc (NASDAQ: NLST) as a long/bullish position for our short term portfolio:

Top 10 Tech Stocks To Buy For 2018: Novellus Systems Inc.(NVLS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nivalis Therapeutics Inc. (NASDAQ: NVLS) dropped 60% on Tuesday to post a new 52-week low of $2.50 after closing at $6.25 on Monday. The stock’s 52-week high is $9.45. Volume of about 4.2million was about 60 times the daily average of around 75,000 shares. The company reported a failed mid-stage trial on its treatment for cystic fibrosis.

  • [By Chris Lange]

    Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi.

  • [By Lisa Levin]

    Nivalis Therapeutics Inc (NASDAQ: NVLS) shares dropped 59 percent to $2.58 after the company reported it failed to demonstrate benefit in absolute change in predicted FEV1 or in Sweat Chloride Reduction at 12 weeks. The failed trial has prompted four Wall Street firms to downgrade the issue including Raymond James, Cowen, Baird and Stifel.

Top 10 Clean Energy Stocks To Watch For 2018

First it was plane makers in Canada and Europe. Now companies in the United States and Brazil might get hitched.

Plane makers Boeing and Embraer issued a joint statement Thursday confirming the “companies are engaged in discussions regarding a potential combination, the basis of which remains under discussion.”

“There is no guarantee a transaction will result from these discussions. Boeing and Embraer do not intend to make any additional comments regarding these discussions,” according to the statement. Any agreement would be subject to approval by their respective boards, shareholders and the Brazilian Government, the statement added.

The Wall Street Journal first reported that Boeing, the world’s largest maker of planes, and Brazil’s Embraer, the third, had held talks about a possible takeover. But approval by the Brazilian Government remained the largest sticking point.

Shares of Embraer (ERJ) rose more than 28% during trading on Thursday.

Top 10 Clean Energy Stocks To Watch For 2018: Roche Holding AG (RHHBY)

Advisors’ Opinion:

  • [By Keith Speights]

    However, Roche (NASDAQOTH:RHHBY) could beat Corbus to market with Actemra. The drug is already approved for treating rheumatoid arthritis and juvenile idiopathic arthritis. Roche expects to file for approval of Actemra in treating system sclerosis in 2018.

  • [By SEEKINGALPHA.COM]

    In fact, Novartis’ RTH258 will be the fourth drug in the market for the treatment of wet age-related macular degeneration, or AMD, behind Avastin (bevacizumab), from Genentech, a subsidiary of Roche (OTCQX:RHHBY), Eylea and Genentech’s Lucentis (ranibizumab). According to the American Academy of Ophthalmology, or AAO, the differences between the three therapies are considered clinically insignificant by many ophthalmologists. Thus, in our view, RTH258 must be priced somewhere between $1,850 for Eylea, and $1,950 for Lucentis, in order for Novartis to be able to compete.

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

  • [By SEEKINGALPHA.COM]

    Sparks preliminary data demonstrated the efficacy in eliminating bleeding but more importantly, the unknowns and variations pose the huge uncertainties when moving forward. What made this worse is the direct comparison with the competitor in the same conference. BioMarin is establishing its leading position in hemophilia A field. Outside the gene therapy for hemophilia A, the recently approved Hemlibra from Roche (OTCQX:RHHBY) and ongoing Phase 3 Fitusiran from Alnylam (NASDAQ: ALNY) could be the direct competitors in this field. The trailing needs time to catch up.

  • [By SEEKINGALPHA.COM]

    AbbVie (ABBV) reported positive trial data from its phase 3 study of venetoclax in combination with Roches (OTCQX:RHHBY) Rituxan in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and showed the venetoclax combo extended progression-free survival compared to bendamustine + Rituxan. I recently covered AbbVie and its pipeline and argued that AbbVie has little to replace Humira with in that pipeline.

  • [By SEEKINGALPHA.COM]

    Medtronic operates both in the therapeutic and diagnostic medical markets throughout the world; the company’s varied product lines face a vast combination of competitors, ranging from large manufacturers with multiple business lines (exemplified by Johnson & Johnson) to smaller manufacturers offering a limited selection of products, like Insulet (NASDAQ:PODD). Other notable competitors include Abbott Labs (NYSE:ABT), C.R. Bard (NYSE:BCR), Baxter (NYSE:BAX), LivaNova (NASDAQ:LIVN), Roche (OTCQX:RHHBY), DexCom (NASDAQ:DXCM) and Tandem (NASDAQ:TNDM).

Top 10 Clean Energy Stocks To Watch For 2018: Avid Technology Inc.(AVID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Avid Technology, Inc. (NASDAQ: AVID) shares were also up, gaining 24 percent to $5.01 following Q3 results. Avid Technology reported Q3 earnings of $0.00 per share on revenue of $105.26 million.

  • [By Monica Gerson]

    Avid Technology, Inc. (NASDAQ: AVID) is estimated to post its quarterly earnings at $0.36 per share on revenue of $144.02 million.

    Consolidated Water Co. Ltd. (NASDAQ: CWCO) is expected to post its quarterly earnings at $0.11 per share on revenue of $15.15 million.

  • [By Anders Bylund]

    Shares of Avid Technology(NASDAQ:AVID) rose 20.3% in April 2017, according to data from S&P Global Market Intelligence.

    So what

    Last month’s share price surge rested on Avid’s release of a coherent cloud-based media production suite. The new version of Avid’s MediaCentral platform takes advantage of the cloud, central storage, and back-end data processing in a way older versions never attempted, modernizing the media production tool in a big way.

Top 10 Clean Energy Stocks To Watch For 2018: Novellus Systems Inc.(NVLS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nivalis Therapeutics Inc (NASDAQ: NVLS) shares dropped 59 percent to $2.58 after the company reported it failed to demonstrate benefit in absolute change in predicted FEV1 or in Sweat Chloride Reduction at 12 weeks. The failed trial has prompted four Wall Street firms to downgrade the issue including Raymond James, Cowen, Baird and Stifel.

  • [By Paul Ausick]

    Nivalis Therapeutics Inc. (NASDAQ: NVLS) dropped 60% on Tuesday to post a new 52-week low of $2.50 after closing at $6.25 on Monday. The stock’s 52-week high is $9.45. Volume of about 4.2million was about 60 times the daily average of around 75,000 shares. The company reported a failed mid-stage trial on its treatment for cystic fibrosis.

  • [By Chris Lange]

    Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi.

Top 10 Clean Energy Stocks To Watch For 2018: Sandstorm Gold Ltd(SAND )

Advisors’ Opinion:

  • [By Rich Duprey]

    Sandstorm Gold (NYSEMKT:SAND) has outperformed the precious metal itself over the past year, with shares rising 35% year to date. Last month it reported third-quarter profits of $7 million, a big U-turn from 2015, when it suffered losses of $5.5 million. In fact, its entire operation was doing better with greater production: lower cash costs, but higher cash margins; and greater operating cash flows, all of which allowed it to pay down its revolving credit facility. That means it has no bank debt and its entire $110 million revolving credit facility is available to make acquisitions.

Top 10 Clean Energy Stocks To Watch For 2018: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

  • [By William Romov]

    Currently trading at $4.52 per share, Viking Therapeutics Inc. (Nasdaq: VKTX) develops drugs to treat fatty liver disease and post-hip surgery rehabilitation. It has the highest share price of the penny stocks on our list today.

Top 10 Clean Energy Stocks To Watch For 2018: Energy XXI Ltd.(EXXI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Energy XXI Ltd (NASDAQ: EXXI) were down 72 percent to $0.181 after the company announced that it and some of its subsidiaries have entered into a Restructuring Support Agreement (RSA) with holders of more than 63 percent of its secured second lien 11.0 percent notes. Energy XXI added that in order to implement the terms of the RSA, it has commenced cases under Chapter 11 of the Bankruptcy Code.

Top 10 Clean Energy Stocks To Watch For 2018: Sigma Designs, Inc.(SIGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sigma Designs Inc (NASDAQ: SIGM) shares dropped 30 percent to $5.43. Sigma Designs reported fiscal third-quarter net income of $221,000 on revenue of $62.7 million.

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

  • [By Paul Ausick]

    Sigma Designs Inc. (NASDAQ: SIGM) dropped about 34% on Wednesday to post a new 52-week low of $5.20 against a 52-week high of $8.60 and a Tuesday close of $7.75. Volume of about 6.2 million was about 25 times the daily average of around 280,000. The company reported so-so earnings on Tuesday and the stock was downgraded and price targets lowered by several analysts.

Top 10 Clean Energy Stocks To Watch For 2018: Zimmer Biomet Holdings, Inc.(ZBH)

Advisors’ Opinion:

  • [By Keith Speights]

    The three top dividend stocks in the dentistry industry are Patterson Companies (NASDAQ:PDCO), Zimmer Biomet Holdings (NYSE:ZBH), and Danaher (NYSE:DHR). But two of these, Zimmer Biomet and Danaher, pay out only small dividends.

  • [By WWW.GURUFOCUS.COM]

    For the details of Focused Investors LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Focused+Investors+LLC

    These are the top 5 holdings of Focused Investors LLCZimmer Biomet Holdings Inc (ZBH) – 1,433,300 shares, 6.32% of the total portfolio. Shares added by 23.22%CVS Health Corp (CVS) – 2,120,700 shares, 6.01% of the total portfolio. Shares added by 19.73%Johnson & Johnson (JNJ) – 1,285,900 shares, 5.78% of the total portfolio. Shares reduced by 0.67%American Express Co (AXP) – 1,990,300 shares, 5.68% of the total portfolio. Shares reduced by 0.33%Anthem Inc (ANTM) – 944,800 shares, 5.64% of the total portfolio. Sh

Top 10 Clean Energy Stocks To Watch For 2018: Federated Investors, Inc.(FII)

Advisors’ Opinion:

  • [By Gregg Greenberg]

     Stocks of Federated Investors (FII) fell approximately 9% in 2015, yet Oja expects a big turnaround in 2016, once again due to the prospect of higher rates ahead. 

     

    "The money market fund business, which is unprofitable now, should become more profitable as rates rise because Federated has to reimburse for the servicing fees for these funds," said Oja, who also admires the fund company’s 3.5% dividend yield. 

     

    Oja added that Federated also has a "good core business of equity and fixed-income asset management." 

Top 10 Clean Energy Stocks To Watch For 2018: DAVIDsTEA Inc.(DTEA)

Advisors’ Opinion:

  • [By Monica Gerson]

    DavidsTea Inc (NASDAQ: DTEA) is expected to post its quarterly earnings at $0.43 per share on revenue of $71.74 million.

    SemiLEDs Corporation (NASDAQ: LEDS) is estimated to post its quarterly earnings.

Top 5 Warren Buffett Stocks To Invest In 2018

Both Amazon.com (NASDAQ:AMZN) and Google’s parent company,Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), are trading near their all-time highs. Amazon’s stock has climbed so much in the past 12 months, it’s made its founder and CEO Jeff Bezos the second wealthiest person in the world, recently surpassing Warren Buffett and Amancio Ortega. Alphabet shares are up a modest 11%, compared with Amazon’s 51% increase.

But investors can’t dwell too much on the past. They need to look to the future to determine which stocks offer the best opportunities for further gains. Today we’ll compare the two tech giants head to head to determine which is a better buy: Amazon.com or Alphabet.

Image source: Amazon.com.

Amazon is firing on all cylinders

Amazon’s core retail business is strong. It generated $124 billion in revenue in 2016 across its North American and international retail segments. That’s up 25% from $99 billion in 2015. Amazon’s growth is fueled by increasing Prime membership, which acts as a huge incentive for both customers and merchants to use Amazon’s marketplace before looking elsewhere. A survey from BloomReach found that 55% of online shoppers begin their product search on Amazon.com.

Top 5 Warren Buffett Stocks To Invest In 2018: TheStreet, Inc.(TST)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

  • [By Steven Goldberg]

    Launched in August 2001, Action Alerts PLUS Portfolio has been a centerpiece of the financial advice offered by TheStreet.com. The website belongs to TheStreet, Inc. (TST), a publicly traded company that Cramer co-founded in 1996. PLUS Portfolio subscribers, who pay $15 a month, always get the recommendations before Cramer buys them for the portfolio, the Wharton paper reports. Likewise, subscribers get Cramers picks before he airs them on Mad Money.

Top 5 Warren Buffett Stocks To Invest In 2018: Acacia Communications, Inc. (ACIA)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap networking stock Acacia Communications (NASDAQ: ACIA) is the second most shorted stock on the Nasdaq with short interest of 54.23% according to Highshortinterest.com. Acacia Communications is a small cap developer, manufacturers and seller high-speed coherent optical interconnect products that are designed to transform communications networks through improvements in performance, capacity and cost. By leveraging silicon technology to build optical interconnects, a process Acacia Communications refers to as the siliconization of optical interconnect, the Company is able to offer products at higher speeds and density with lower power consumption, that meet the needs of cloud and service providers and can be easily integrated in a cost-effective manner with existing network equipment.

  • [By Scott Rubin]

    Shares of Acacia Communications, Inc. (NASDAQ: ACIA) soared on the back of the company's second-quarter earnings results, closing the session up 41 percent to $95.67. Planet Fitness Inc (NYSE: PLNT) added 10 percent after reporting better-than expected results. The stock closed at $22.36. Steel stocks fell during Friday's session. United States Steel Corporation (NYSE: X) lost 7 percent to $21.06 and AK Steel Holding Corporation (NYSE: AKS) fell 6 percent to $5.03.

  • [By Lisa Levin]

    Acacia Communications, Inc. (NASDAQ: ACIA) was down, falling around 14 percent to $54.34 after the company issued a weak forecast for the current quarter. However, the company’s Q4 results exceeded expectations.

  • [By Evan Niu, CFA]

    Shares of optical component companies have dropped today, includingOclaro (NASDAQ:OCLR), Acacia (NASDAQ:ACIA), Lumentum (NASDAQ:LITE), and Finisar (NASDAQ:FNSR), whose shares were down 11%, 11%, 6%, and 3%, respectively, as of 3:30 p.m. EDT, after the U.S. broadened its investigation regarding compliance with sanctions programs.

Top 5 Warren Buffett Stocks To Invest In 2018: Trevena, Inc.(TRVN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Trevena Inc. (NASDAQ: TRVN) dropped about 6.3% Thursday, to post a new 52-week low of $3.70 after closing at $3.95 on Wednesday. The stock’s 52-week high is $9.73. Volume was nearly 5 times the daily average of around 700,000 shares. The company’s pain-killing drug got mixed results in a trial result reported Tuesday.

  • [By Maxx Chatsko]

    Shares of clinical-stage biopharma Trevena (NASDAQ:TRVN) fell nearly 12% today after it reported full-year 2016 earnings. The pre-revenue company didn’t announce any surprises one way or the other. However, investors appear to be considering the near-term consequences of swelling expenses that won’t be offset by product sales anytime soon.

  • [By Chris Lange]

    Trevena Inc. (NASDAQ: TRVN) reported positive results from two late-stage clinical trials that work to treat post-surgical pain. The company intends to submit these results to the FDA for a marketing approval agreement in the fourth quarter. Previously, oliceridine was approved for a breakthrough designation by the agency.

Top 5 Warren Buffett Stocks To Invest In 2018: Novellus Systems Inc.(NVLS)

Advisors’ Opinion:

  • [By Chris Lange]

    Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi.

  • [By Lisa Levin]

    Nivalis Therapeutics Inc (NASDAQ: NVLS) shares dropped 59 percent to $2.58 after the company reported it failed to demonstrate benefit in absolute change in predicted FEV1 or in Sweat Chloride Reduction at 12 weeks. The failed trial has prompted four Wall Street firms to downgrade the issue including Raymond James, Cowen, Baird and Stifel.

  • [By Paul Ausick]

    Nivalis Therapeutics Inc. (NASDAQ: NVLS) dropped 60% on Tuesday to post a new 52-week low of $2.50 after closing at $6.25 on Monday. The stock’s 52-week high is $9.45. Volume of about 4.2million was about 60 times the daily average of around 75,000 shares. The company reported a failed mid-stage trial on its treatment for cystic fibrosis.

Top 5 Warren Buffett Stocks To Invest In 2018: Credit Suisse Group(CS)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

  • [By Money Morning News Team]

    That’s why Krauth predicts the price of gold will hit $1,400 by the end of the year. Many analysts from banks likeCredit SuisseGroup AG (NYSE ADR: CS) even see gold going as high as $1,500.

  • [By Wayne Duggan] Related DB Deutsche Bank In The Tank Mike Khouw Sees Unusual Options Activity In Deutsche Bank 33 Large Banks On The Federal Reserve's Radar In 2016 (Seeking Alpha)
    Related CS Earnings Scheduled For February 4, 2016 Blockchain Moves Forward In The Financial Industry Credit Suisse Group AG (CS) Tidjane Thiam on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)

    The latest credit default swap (CDS) data from BMO Capital Markets indicate a number of investors are growing increasingly concerned about the one-year outlook for capital markets. In a new report, analyst Mark Steele discussed the recent surge in one-year CDS activity, and what it means for the market.

Top 10 Tech Stocks To Own For 2018

5 Worst States for Insurance Producer Fines

5 Worst States for Insurance Producer Fines

5 Worst States for Insurance Producer Fines

News that Donald Trump Jr. met with a Russian lawyer described as having potentially damaging information on Hillary Clinton during last year’s presidential campaign dims the U.S. economic outlook, according to Dan Ivascyn, group chief investment officer at Pacific Investment Management Co.

President Donald Trump’s key initiatives such as a health-care overhaul, tax cuts and fiscal stimulus are less likely to win approval before the 2018 mid-term elections as controversies build, Ivascyn said.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

On Twitter, the bond king shares his views on the 10-year and sounds off on volatility and Pimcos treatment of…

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. padding: 0px 81px;width: inherit; Retirement Wire

Your resource for news, research and analysis to help you deliver more effective outcomes to your clients. Resources How to thrive in a post-DOL rule world

Tools to help you survive in the post-DOL rule world.

Top 10 Tech Stocks To Own For 2018: Illinois Tool Works Inc.(ITW)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    There are lots of stories like that out there these days. People were perplexed about the Illinois Tool Works (ITW) and Cummins Engine (CMI) and Caterpillar (CAT) quarters, but they turned out to be classic buying opportunities after years of being sell opportunities if the stocks had run. I can’t explain to you how amazing that is. Here are three stocks that have spent months and months in purgatory when they have missed or guided down or slashed forecasts. Now they are up gigantically.

Top 10 Tech Stocks To Own For 2018: Towerstream Corporation(TWER)

Advisors’ Opinion:

  • [By Lisa Levin]

    Towerstream Corporation (NASDAQ: TWER) shares were also up, gaining 9 percent to $3.49. Towerstream is scheduled to report Q2 financial results on August 9, 2016.

Top 10 Tech Stocks To Own For 2018: Harte-Hanks, Inc.(HHS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Harte Hanks Inc (NYSE: HHS) were down 19 percent to $2.95. Harte Hanks entered into a new $110 million credit facility over 5 years.

    TravelCenters of America LLC (NYSE: TA) was down, falling around 18 percent to $7.75. TravelCenters of America reported a Q4 loss of $0.04 per share on revenue of $1.35 billion.

Top 10 Tech Stocks To Own For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Cognizant Technology Solutions Corp (NASDAQ: CTSH) to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion. Cognizant Technology shares gained 1.75 percent to $58.60 in after-hours trading.

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

  • [By Lisa Levin]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) reported better-than-expected earnings for its first quarter, but issued a weak guidance for the current quarter.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

Top 10 Tech Stocks To Own For 2018: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 10 Tech Stocks To Own For 2018: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows ViaSat, Inc plus mid to large cap communications stockslikeHarris Corporation (NYSE: HRS) and L-3 Communications Holdings, Inc (NYSE: LLL)had been moving in tandem until last yearwhile small cap Gogo Inc has underperformed:

  • [By Peter Graham]

    Headquartered in New York City, large cap L3 Technologies Inc (NYSE: LLL) employs approximately 38,000 people worldwide and is a leading provider of a broad range of communication, electronic and sensor systems used on military, homeland security and commercial platforms. L3 is also a prime contractor in aerospace systems, security and detection systems, and pilot training. The Company reported 2016 sales of $10.5 billion.

  • [By Chris Lange]

    L3 Technologies Inc. (NYSE: LLL) just hosted its investor day and projected that it wants to be considered among the top defense firms. Multiple analysts have raised their target prices. RBC raised its rating to Outperform from Sector Perform and its target price to $239 from $202. Other price target hikes were seen as follows: Cowen to $210 from $200, Jefferies to $201 from $188 and JPMorgan to $220 from $205.

  • [By Paul Ausick]

    Five teams are expected to compete for the contract: Boeing Co. (NYSE: BA) has joined with Saab to offer a clean-sheet design; Northrop Grumman Corp. (NYSE: NOC) has teamed up with BAE Systems and L-3 Communications Holdings Inc. (NYSE: LLL) on another clean-sheet design; Lockheed Martin Corp. (NYSE: LMT) and Korea Aerospace Industries (KAI) are going with a modified KAI T-50; Raytheon Corp. (NYSE: RTN) has joined with Italy’s Leonardo and Canada’s CAE Inc. (NYSE: CAE) on a version of Leonardo’s M-346 trainer that it calls the T-100; and privately held Sierra Nevada has partnered with Turkish Aerospace Industries (TAI) on another clean-sheet design.

Top 10 Tech Stocks To Own For 2018: Novellus Systems Inc.(NVLS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nivalis Therapeutics Inc. (NASDAQ: NVLS) dropped 60% on Tuesday to post a new 52-week low of $2.50 after closing at $6.25 on Monday. The stock’s 52-week high is $9.45. Volume of about 4.2million was about 60 times the daily average of around 75,000 shares. The company reported a failed mid-stage trial on its treatment for cystic fibrosis.

  • [By Chris Lange]

    Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi.

  • [By Lisa Levin]

    Nivalis Therapeutics Inc (NASDAQ: NVLS) shares dropped 59 percent to $2.58 after the company reported it failed to demonstrate benefit in absolute change in predicted FEV1 or in Sweat Chloride Reduction at 12 weeks. The failed trial has prompted four Wall Street firms to downgrade the issue including Raymond James, Cowen, Baird and Stifel.

Top 10 Tech Stocks To Own For 2018: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Peter Graham]

    After the market closed yesterday, mid cap electronic manufacturing services (EMS) stock Jabil Circuit, Inc (NYSE: JBL), who gets around 24% of revenue from Apple Inc (NASDAQ: AAPL), reported fiscal Q4 revenue and profit that topped analysts expectations. Net revenue for the fourth quarterfell 5% to$4.4 billion and GAAP net income was $38 million versus $87.7 million. For the year, net revenue increased 3% to $18.4 billion and GAAP net incomewas $254 million versus $284 million. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows Sanmina Corp along with potential peersCelestica Inc (NYSE: CLS), Jabil Circuit, Inc (NYSE: JBL) and Flextronics International Ltd (NASDAQ: FLEX)all having similar looking charts; but SANM has been the outperformer:

  • [By Chris Lange]

    And Jabil Inc. (NYSE: JBL) will report its fiscal first-quarter results on Thursday. The consensus estimates are EPS of $0.79 and revenue of $5.5 billion. Shares traded at $27.88 on Friday’s close, in a 52-week range of $21.31 to $31.70. The consensus price target is $32.23.

  • [By Lisa Levin]

    Shares of Jabil Circuit, Inc. (NYSE: JBL) were down 10 percent to $19.86 as the company reported weaker-than-expected results for its fiscal second quarter and lowered its full-year outlook.

Top 10 Tech Stocks To Own For 2018: Tencent Holdings Ltd (700)

Advisors’ Opinion:

  • [By Belinda Cao]

    Sohu.com Inc. (SOHU), which sold a stake in its search unit to Tencent Holdings Ltd. (700), advanced 11 percent for the week to $72.06. It retreated 5.9 percent Sept. 20. Tencent, Chinas biggest Internet company by market value, paid $448 million for a 36.5 percent stake in Sohus Sogou unit last week and merge its own search service with Sogou.

Top 10 Tech Stocks To Own For 2018: EchoStar Corporation(SATS)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Incidentally, Facebook has secured shareholder approval for issuing Class C share at its shareholder meeting in June 2016, although it is yet to issue the shares.

    Other Companies With Dual-class Voting Shares
    Berkshire Hathaway Inc. (NYSE: BRK-A) and (NYSE: BRK-A), with Class A shares having 1/10th interest in the company but only 1/200th of voting power. Echostar Corporation (NASDAQ: SATS)’s CEO Charlie Ergen owns a 43.4 percent stake in the company through his holding of Class B shares but has 63.6 percent of the voting rights. Ford Motor Company (NYSE: F) uses the dual-class structure to give its founding family more voting power.

    Related Links:

Top 5 Medical Stocks To Buy Right Now

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is watching its shares drop on Tuesday after the company provided an update on its regulatory pathway for its Fabry Disease treatment. After the company had several collaborative discussions with the U.S. Food and Drug Administration (FDA), Amicus plans to collect additional data on gastrointestinal (GI) symptoms in Fabry patients who have an amenable mutation.

During its review of the briefing document submitted and in discussions with Amicus, the FDA acknowledged that significant unmet medical need exists in Fabry disease. The agency also indicated that kidney globotriaosylceramide (GL-3) is currently not considered a basis for an accelerated approval.

More than 50% of patients with Fabry disease report or show GI signs and symptoms, including diarrhea, abdominal pain, constipation, nausea, and vomiting. Amicus previously presented positive GI data in a completed Phase 3 randomized, placebo controlled Study 011 (FACETS) in treatment-na茂ve Fabry patients with amenable mutations.

Top 5 Medical Stocks To Buy Right Now: ManpowerGroup(MAN)

Advisors’ Opinion:

  • [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
    Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
    Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
    General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
    Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
    Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
    Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
    SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
    ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
    Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
    Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
    WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
  • [By Bryan Murphy]

    Look out ManpowerGroup Inc. (NYSE:MAN). And Robert Half International Inc. (NYSE:RHI)? You may want to look over your shoulder as well. A young-and-hungry staffing solutions competitor named Staffing 360 Solutions Inc (NASDAQ:STAF) is coming on strong, and just proved it again today. Some of its preliminary fiscal Q2 numbers were reported today, and they extend what’s become a long-term growth streak.

    The definition of a roll-up isn’t a hard and fast one, though even the broad brush strokes paint a pretty clear picture. Investopedia defines a roll-up (also known as a “roll up” or a “rollup”) a merger that occurs when investors (often private equity firms) buy up companies in the same market and merge them together. Roll-ups combine multiple small companies into something bigger and better to be able to enjoy economies of scale. Private equity firms use roll-ups to rationalize competition in crowded and/or fragmented markets and to combine companies with complementary capabilities into a full-service business.

    It’s also the kind of strategy Staffing 360 Solutions is executing, with great success. For the fiscal quarter ending in November, Staffing 360 Solutions has pre-reported revenue of $47 million, and a gross profit of $8.1 million. Those figures are up 14% and 8%, respectively, year-over-year.

  • [By Bryan Murphy]

    Staffing agencies like Robert Half International Inc. (NYSE:RHI) and ManpowerGroup Inc. (NYSE:MAN) may want to look over their shoulder. Though both are bigger and more established, their size and the waning need for physical, human workers in an increasingly-digital and roboticized world ultimately works against both organizations. That paradigm shift doesn’t matter much to a young, up-coming-staffing agency called Staffing 360 Solutions Inc (NASDAQ:STAF) though. Indeed, the trend of computer-based everything leaves Staffing 360 Solutions in the proverbial cat-bird’s seat. Its fiscal Q2 numbers verify the company is in the right place at the right time.

    Those numbers? Revenue of $47.1 million was up 14%, and gross profits of $8.1 million were higher by 8.4% on a year-over-year basis. Moreover, the net loss of $1.5 million was a marked improvement on the year-ago loss of $3.5 million, and the EBITDA of $1.4 million was about the same. Operating expenses fell from 22% of revenue a year earlier to only 17% last quarter, with more such progress on the way.

    Perhaps most important, Staffing 360 Solutions saw organic growth of 7%, meaning the top line bumped up by that much not because of acquisitions, but because it’s existing divisions expanded their client base and billings by 7%.

    And last quarter’s progress has been the norm for several quarters now.

    While STAF is proving outpacing the growth from bigger names like ManpowerGroup and Robert Half International, it can’t come as a complete surprise. Staffing 360 Solutions is focused on the IT sliver of the staffing industry, connecting companies with the technology-skilled programmers, cybersecurity specialists, and computer networking personnel modern organizations increasingly need.

    There are several data nuggets that point in the same direction, but perhaps none as telling as a recent conclusion from technology research outfit IDC speaks volumes. IDC believes that by the

Top 5 Medical Stocks To Buy Right Now: Novellus Systems Inc.(NVLS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nivalis Therapeutics Inc. (NASDAQ: NVLS) dropped 60% on Tuesday to post a new 52-week low of $2.50 after closing at $6.25 on Monday. The stock’s 52-week high is $9.45. Volume of about 4.2million was about 60 times the daily average of around 75,000 shares. The company reported a failed mid-stage trial on its treatment for cystic fibrosis.

  • [By Lisa Levin]

    Nivalis Therapeutics Inc (NASDAQ: NVLS) shares dropped 59 percent to $2.58 after the company reported it failed to demonstrate benefit in absolute change in predicted FEV1 or in Sweat Chloride Reduction at 12 weeks. The failed trial has prompted four Wall Street firms to downgrade the issue including Raymond James, Cowen, Baird and Stifel.

  • [By Chris Lange]

    Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi.

Top 5 Medical Stocks To Buy Right Now: RPX Corporation(RPXC)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of risk management company RPX Corp. (NASDAQ:RPXC) popped as much as 15% in trading Wednesday after buyout rumors started to swirl in the market. At 2:55 p.m. EST, shares had settled down to an 11.2% gain on the day.

Top 5 Medical Stocks To Buy Right Now: Santander Consumer USA Holdings Inc.(SC)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested going long on small cap consumer financestock Santander Consumer USA Holdings (NYSE: SC):

  • [By Wayne Duggan]

    Height Financial Services analyst Edwin Groshans believes Credit Acceptance Corp, Santander Consumer USA Holdings Inc (NYSE: SC), Ally Financial Inc (NYSE: ALLY) and Capital One Financial Corp. (NYSE: COF).

Top 5 Medical Stocks To Buy Right Now: NCI Building Systems, Inc.(NCS)

Advisors’ Opinion:

  • [By Scott Rubin]

    Equity gainers on the day included Chico's FAS, Inc. (NYSE: CHS), which surged more than 12 percent on the day, and Himax Technologies (NASDAQ: HIMX), which climbed almost 9 percent in the wake of an afternoon rally. Losers included NCI Building Systems Inc. (NYSE: NCS), which fell 15 percent after earnings, and H&R Block inc (NYSE: HRB), which fell almost 11 percent on the day after its Q1 results.

  • [By Lisa Levin]

    NCI Building Systems Inc (NYSE: NCS) was down, falling around 14 percent to $15.27. NCI Building Systems reported Q3 adjusted earnings of $0.33 per share on revenue of $462.4 million.

  • [By Monica Gerson]

    NCI Building Systems Inc (NYSE: NCS) posted upbeat results for its second quarter on Tuesday. NCI Building Systems shares rose 1.24 percent to $16.30 in the after-hours trading session.

  • [By Jim Robertson]

    Yesterday, small cap NCI Building Systems (NYSE: NCS) sank 20.54% after the maker of metal products for the nonresidential building industry reported disappointing Q3 results and cut its sales outlook. NCI Building Systems is one of North America’s largest integrated manufacturers and marketers of coatings, components and metal buildings for the nonresidential building industry and is comprised of a family of companies operating manufacturing facilities across the United States, Canada, Mexico and China (with additional sales and distribution offices throughout the United States and Canada).